RSA 126-Z:1 Definitions.

In this chapter:
I. "Eligible patient" means a person to whom all of the following apply:
(a) The person has been diagnosed by the person's physician with a life-threatening disease or condition.
(b) The person has already tried or is not a candidate for eligible United States Food and Drug Administration (FDA) approved treatment options for their disease or condition.
(c) The person is unable to participate in a clinical trial involving the eligible investigational drug, biologic or device.
(d) The person has given written informed consent for the use of the investigational drug, biological product, or device or, if the patient is a minor or lacks the mental capacity to provide informed consent, a parent or legal guardian has given written informed con